Bahnbrechende Technologie kombiniert rekombinantes menschliches Kollagen und Hyaluronsäure für sofortige, lang anhaltende Ergebnisse SEOUL, Südkorea, 16. Februar 2025 /PRNewswire/ — MAYPHARM CO., LTD. stellt mit Stolz SKINCOLLA vor, den weltweit ersten rekombinanten menschlichen…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.